GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » Cash-to-Debt

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Cash-to-Debt : 0.00 (As of . 20)


View and export this data going back to 2018. Start your Free Trial

What is Shafa Darou Pharmaceutical Investment Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Shafa Darou Pharmaceutical Investment Co's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Shafa Darou Pharmaceutical Investment Co couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt or its related term are showing as below:

XTEH:SHFA1's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.93
* Ranked among companies with meaningful Cash-to-Debt only.

Shafa Darou Pharmaceutical Investment Co Cash-to-Debt Historical Data

The historical data trend for Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Shafa Darou Pharmaceutical Investment Co Cash-to-Debt Chart

Shafa Darou Pharmaceutical Investment Co Annual Data
Trend
Cash-to-Debt

Shafa Darou Pharmaceutical Investment Co Semi-Annual Data
Cash-to-Debt

Competitive Comparison of Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt falls into.



Shafa Darou Pharmaceutical Investment Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Shafa Darou Pharmaceutical Investment Co's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Shafa Darou Pharmaceutical Investment Co's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shafa Darou Pharmaceutical Investment Co  (XTEH:SHFA1) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Shafa Darou Pharmaceutical Investment Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Shafa Darou Pharmaceutical Investment Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Fakhar Moghadam Street, Dadman Street, No. 13, At the corner of East 4th Golbarg Alley, Shahrak-e Gharb, Tehran, IRN
Shafa Darou Pharmaceutical Investment Co is a pharmaceutical holding company. Along with its subsidiaries it produces injectable, non-injectable, and antibiotics.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Headlines

No Headlines